nodes	percent_of_prediction	percent_of_DWPC	metapath
Vardenafil—Tearing eyes—Docetaxel—head and neck cancer	0.0386	0.0439	CcSEcCtD
Vardenafil—Sildenafil—CYP1A1—head and neck cancer	0.026	1	CrCbGaD
Vardenafil—Angina unstable—Docetaxel—head and neck cancer	0.0251	0.0285	CcSEcCtD
Vardenafil—Dysaesthesia—Fluorouracil—head and neck cancer	0.0203	0.0231	CcSEcCtD
Vardenafil—Dysaesthesia—Docetaxel—head and neck cancer	0.0146	0.0167	CcSEcCtD
Vardenafil—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.0129	0.0147	CcSEcCtD
Vardenafil—Creatinine increased—Hydroxyurea—head and neck cancer	0.0128	0.0146	CcSEcCtD
Vardenafil—Photophobia—Vinblastine—head and neck cancer	0.0126	0.0143	CcSEcCtD
Vardenafil—Myocardial ischaemia—Fluorouracil—head and neck cancer	0.0109	0.0124	CcSEcCtD
Vardenafil—Eye irritation—Fluorouracil—head and neck cancer	0.0103	0.0117	CcSEcCtD
Vardenafil—Lacrimation increased—Fluorouracil—head and neck cancer	0.00952	0.0108	CcSEcCtD
Vardenafil—Redness—Docetaxel—head and neck cancer	0.00938	0.0107	CcSEcCtD
Vardenafil—Burning sensation—Docetaxel—head and neck cancer	0.00912	0.0104	CcSEcCtD
Vardenafil—Face oedema—Hydroxyurea—head and neck cancer	0.00855	0.00973	CcSEcCtD
Vardenafil—Scotoma—Docetaxel—head and neck cancer	0.00834	0.00949	CcSEcCtD
Vardenafil—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.00829	0.00944	CcSEcCtD
Vardenafil—Photophobia—Fluorouracil—head and neck cancer	0.00824	0.00938	CcSEcCtD
Vardenafil—Angina pectoris—Vinblastine—head and neck cancer	0.00817	0.0093	CcSEcCtD
Vardenafil—Oesophagitis—Fluorouracil—head and neck cancer	0.00802	0.00913	CcSEcCtD
Vardenafil—Breast disorder—Hydroxyurea—head and neck cancer	0.008	0.0091	CcSEcCtD
Vardenafil—Myocardial ischaemia—Docetaxel—head and neck cancer	0.00788	0.00897	CcSEcCtD
Vardenafil—Eye irritation—Docetaxel—head and neck cancer	0.00742	0.00844	CcSEcCtD
Vardenafil—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00737	0.00839	CcSEcCtD
Vardenafil—Myocardial infarction—Vinblastine—head and neck cancer	0.00733	0.00835	CcSEcCtD
Vardenafil—Lacrimation increased—Docetaxel—head and neck cancer	0.00687	0.00782	CcSEcCtD
Vardenafil—Infestation NOS—Hydroxyurea—head and neck cancer	0.00682	0.00776	CcSEcCtD
Vardenafil—Infestation—Hydroxyurea—head and neck cancer	0.00682	0.00776	CcSEcCtD
Vardenafil—Amnesia—Fluorouracil—head and neck cancer	0.00678	0.00772	CcSEcCtD
Vardenafil—Haemoglobin—Vinblastine—head and neck cancer	0.00675	0.00768	CcSEcCtD
Vardenafil—Haemorrhage—Vinblastine—head and neck cancer	0.00672	0.00764	CcSEcCtD
Vardenafil—Hypoaesthesia—Vinblastine—head and neck cancer	0.00668	0.0076	CcSEcCtD
Vardenafil—Pharyngitis—Vinblastine—head and neck cancer	0.00666	0.00759	CcSEcCtD
Vardenafil—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00645	0.00734	CcSEcCtD
Vardenafil—Haemoglobin—Hydroxyurea—head and neck cancer	0.00616	0.00701	CcSEcCtD
Vardenafil—Influenza like illness—Docetaxel—head and neck cancer	0.00615	0.007	CcSEcCtD
Vardenafil—Haemorrhage—Hydroxyurea—head and neck cancer	0.00612	0.00697	CcSEcCtD
Vardenafil—PDE11A—epithelium—head and neck cancer	0.00586	0.142	CbGeAlD
Vardenafil—Oesophagitis—Docetaxel—head and neck cancer	0.00579	0.00659	CcSEcCtD
Vardenafil—Angiopathy—Hydroxyurea—head and neck cancer	0.00556	0.00632	CcSEcCtD
Vardenafil—Dysphagia—Fluorouracil—head and neck cancer	0.00551	0.00627	CcSEcCtD
Vardenafil—Ill-defined disorder—Vinblastine—head and neck cancer	0.00542	0.00617	CcSEcCtD
Vardenafil—Angina pectoris—Fluorouracil—head and neck cancer	0.00536	0.00611	CcSEcCtD
Vardenafil—Erythema—Hydroxyurea—head and neck cancer	0.00533	0.00607	CcSEcCtD
Vardenafil—Malaise—Vinblastine—head and neck cancer	0.00527	0.006	CcSEcCtD
Vardenafil—Vertigo—Vinblastine—head and neck cancer	0.00525	0.00598	CcSEcCtD
Vardenafil—Convulsion—Vinblastine—head and neck cancer	0.00506	0.00576	CcSEcCtD
Vardenafil—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00503	0.00572	CcSEcCtD
Vardenafil—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00495	0.00563	CcSEcCtD
Vardenafil—Discomfort—Vinblastine—head and neck cancer	0.00492	0.0056	CcSEcCtD
Vardenafil—Hot flush—Docetaxel—head and neck cancer	0.00492	0.0056	CcSEcCtD
Vardenafil—Infestation—Fluorouracil—head and neck cancer	0.00491	0.00559	CcSEcCtD
Vardenafil—Infestation NOS—Fluorouracil—head and neck cancer	0.00491	0.00559	CcSEcCtD
Vardenafil—Menopausal symptoms—Docetaxel—head and neck cancer	0.00487	0.00555	CcSEcCtD
Vardenafil—Visual disturbance—Docetaxel—head and neck cancer	0.00485	0.00552	CcSEcCtD
Vardenafil—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00484	0.00551	CcSEcCtD
Vardenafil—Myocardial infarction—Fluorouracil—head and neck cancer	0.00481	0.00548	CcSEcCtD
Vardenafil—Malaise—Hydroxyurea—head and neck cancer	0.00481	0.00547	CcSEcCtD
Vardenafil—Conjunctivitis—Fluorouracil—head and neck cancer	0.00477	0.00543	CcSEcCtD
Vardenafil—Epistaxis—Fluorouracil—head and neck cancer	0.00463	0.00527	CcSEcCtD
Vardenafil—Convulsion—Hydroxyurea—head and neck cancer	0.00462	0.00526	CcSEcCtD
Vardenafil—Sinusitis—Fluorouracil—head and neck cancer	0.00461	0.00524	CcSEcCtD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00451	0.00513	CcSEcCtD
Vardenafil—Discomfort—Hydroxyurea—head and neck cancer	0.00448	0.0051	CcSEcCtD
Vardenafil—Haemoglobin—Fluorouracil—head and neck cancer	0.00443	0.00504	CcSEcCtD
Vardenafil—Rhinitis—Fluorouracil—head and neck cancer	0.00442	0.00503	CcSEcCtD
Vardenafil—Haemorrhage—Fluorouracil—head and neck cancer	0.00441	0.00502	CcSEcCtD
Vardenafil—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00439	0.00499	CcSEcCtD
Vardenafil—Pharyngitis—Fluorouracil—head and neck cancer	0.00437	0.00498	CcSEcCtD
Vardenafil—Infection—Hydroxyurea—head and neck cancer	0.00432	0.00492	CcSEcCtD
Vardenafil—Paraesthesia—Vinblastine—head and neck cancer	0.00428	0.00488	CcSEcCtD
Vardenafil—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00427	0.00486	CcSEcCtD
Vardenafil—Liver function test abnormal—Docetaxel—head and neck cancer	0.00425	0.00483	CcSEcCtD
Vardenafil—Skin disorder—Hydroxyurea—head and neck cancer	0.00423	0.00481	CcSEcCtD
Vardenafil—Abdominal pain upper—Docetaxel—head and neck cancer	0.0042	0.00478	CcSEcCtD
Vardenafil—Orthostatic hypotension—Docetaxel—head and neck cancer	0.0042	0.00478	CcSEcCtD
Vardenafil—Breast disorder—Docetaxel—head and neck cancer	0.00416	0.00473	CcSEcCtD
Vardenafil—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00414	0.00471	CcSEcCtD
Vardenafil—Cramp muscle—Docetaxel—head and neck cancer	0.00414	0.00471	CcSEcCtD
Vardenafil—PDE11A—thyroid gland—head and neck cancer	0.0041	0.0992	CbGeAlD
Vardenafil—Pain—Vinblastine—head and neck cancer	0.00408	0.00464	CcSEcCtD
Vardenafil—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.00406	0.00462	CcSEcCtD
Vardenafil—Dysphagia—Docetaxel—head and neck cancer	0.00397	0.00452	CcSEcCtD
Vardenafil—Feeling abnormal—Vinblastine—head and neck cancer	0.00393	0.00447	CcSEcCtD
Vardenafil—Gastrointestinal pain—Vinblastine—head and neck cancer	0.0039	0.00444	CcSEcCtD
Vardenafil—Dyspnoea—Hydroxyurea—head and neck cancer	0.00388	0.00441	CcSEcCtD
Vardenafil—Angina pectoris—Docetaxel—head and neck cancer	0.00387	0.00441	CcSEcCtD
Vardenafil—Somnolence—Hydroxyurea—head and neck cancer	0.00387	0.0044	CcSEcCtD
Vardenafil—Erythema—Fluorouracil—head and neck cancer	0.00384	0.00437	CcSEcCtD
Vardenafil—Dyspepsia—Hydroxyurea—head and neck cancer	0.00383	0.00436	CcSEcCtD
Vardenafil—Abdominal pain—Vinblastine—head and neck cancer	0.00377	0.00429	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00376	0.00428	CcSEcCtD
Vardenafil—Pain—Hydroxyurea—head and neck cancer	0.00372	0.00423	CcSEcCtD
Vardenafil—PDE6H—head—head and neck cancer	0.00364	0.088	CbGeAlD
Vardenafil—Vision blurred—Fluorouracil—head and neck cancer	0.00362	0.00412	CcSEcCtD
Vardenafil—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00359	0.00408	CcSEcCtD
Vardenafil—Infestation—Docetaxel—head and neck cancer	0.00354	0.00403	CcSEcCtD
Vardenafil—Infestation NOS—Docetaxel—head and neck cancer	0.00354	0.00403	CcSEcCtD
Vardenafil—Hypersensitivity—Vinblastine—head and neck cancer	0.00351	0.004	CcSEcCtD
Vardenafil—PDE6G—head—head and neck cancer	0.0035	0.0847	CbGeAlD
Vardenafil—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00349	0.00398	CcSEcCtD
Vardenafil—Myocardial infarction—Docetaxel—head and neck cancer	0.00347	0.00395	CcSEcCtD
Vardenafil—Conjunctivitis—Docetaxel—head and neck cancer	0.00344	0.00392	CcSEcCtD
Vardenafil—Asthenia—Vinblastine—head and neck cancer	0.00342	0.0039	CcSEcCtD
Vardenafil—Hepatobiliary disease—Docetaxel—head and neck cancer	0.00335	0.00381	CcSEcCtD
Vardenafil—Epistaxis—Docetaxel—head and neck cancer	0.00334	0.0038	CcSEcCtD
Vardenafil—Convulsion—Fluorouracil—head and neck cancer	0.00332	0.00378	CcSEcCtD
Vardenafil—Myalgia—Fluorouracil—head and neck cancer	0.00327	0.00372	CcSEcCtD
Vardenafil—Chest pain—Fluorouracil—head and neck cancer	0.00327	0.00372	CcSEcCtD
Vardenafil—Diarrhoea—Vinblastine—head and neck cancer	0.00326	0.00372	CcSEcCtD
Vardenafil—Discomfort—Fluorouracil—head and neck cancer	0.00323	0.00367	CcSEcCtD
Vardenafil—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00321	0.00365	CcSEcCtD
Vardenafil—Haemoglobin—Docetaxel—head and neck cancer	0.0032	0.00364	CcSEcCtD
Vardenafil—Rhinitis—Docetaxel—head and neck cancer	0.00319	0.00363	CcSEcCtD
Vardenafil—Haemorrhage—Docetaxel—head and neck cancer	0.00318	0.00362	CcSEcCtD
Vardenafil—Hypoaesthesia—Docetaxel—head and neck cancer	0.00317	0.0036	CcSEcCtD
Vardenafil—Pharyngitis—Docetaxel—head and neck cancer	0.00316	0.00359	CcSEcCtD
Vardenafil—Dizziness—Vinblastine—head and neck cancer	0.00315	0.00359	CcSEcCtD
Vardenafil—Urinary tract disorder—Docetaxel—head and neck cancer	0.00314	0.00358	CcSEcCtD
Vardenafil—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00313	0.00356	CcSEcCtD
Vardenafil—Connective tissue disorder—Docetaxel—head and neck cancer	0.00313	0.00356	CcSEcCtD
Vardenafil—Asthenia—Hydroxyurea—head and neck cancer	0.00312	0.00355	CcSEcCtD
Vardenafil—Urethral disorder—Docetaxel—head and neck cancer	0.00312	0.00355	CcSEcCtD
Vardenafil—Infection—Fluorouracil—head and neck cancer	0.00311	0.00354	CcSEcCtD
Vardenafil—Nervous system disorder—Fluorouracil—head and neck cancer	0.00307	0.0035	CcSEcCtD
Vardenafil—Visual impairment—Docetaxel—head and neck cancer	0.00307	0.00349	CcSEcCtD
Vardenafil—Tachycardia—Fluorouracil—head and neck cancer	0.00306	0.00348	CcSEcCtD
Vardenafil—Vomiting—Vinblastine—head and neck cancer	0.00303	0.00345	CcSEcCtD
Vardenafil—Headache—Vinblastine—head and neck cancer	0.00299	0.0034	CcSEcCtD
Vardenafil—Diarrhoea—Hydroxyurea—head and neck cancer	0.00298	0.00339	CcSEcCtD
Vardenafil—Eye disorder—Docetaxel—head and neck cancer	0.00297	0.00338	CcSEcCtD
Vardenafil—Flushing—Docetaxel—head and neck cancer	0.00295	0.00336	CcSEcCtD
Vardenafil—Cardiac disorder—Docetaxel—head and neck cancer	0.00295	0.00336	CcSEcCtD
Vardenafil—Hypotension—Fluorouracil—head and neck cancer	0.00293	0.00333	CcSEcCtD
Vardenafil—Angiopathy—Docetaxel—head and neck cancer	0.00289	0.00329	CcSEcCtD
Vardenafil—Dizziness—Hydroxyurea—head and neck cancer	0.00288	0.00327	CcSEcCtD
Vardenafil—Immune system disorder—Docetaxel—head and neck cancer	0.00287	0.00327	CcSEcCtD
Vardenafil—Mediastinal disorder—Docetaxel—head and neck cancer	0.00287	0.00326	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00285	0.00325	CcSEcCtD
Vardenafil—Nausea—Vinblastine—head and neck cancer	0.00283	0.00323	CcSEcCtD
Vardenafil—Insomnia—Fluorouracil—head and neck cancer	0.00283	0.00322	CcSEcCtD
Vardenafil—Paraesthesia—Fluorouracil—head and neck cancer	0.00281	0.0032	CcSEcCtD
Vardenafil—Dyspnoea—Fluorouracil—head and neck cancer	0.00279	0.00318	CcSEcCtD
Vardenafil—Mental disorder—Docetaxel—head and neck cancer	0.00279	0.00317	CcSEcCtD
Vardenafil—Somnolence—Fluorouracil—head and neck cancer	0.00278	0.00317	CcSEcCtD
Vardenafil—Erythema—Docetaxel—head and neck cancer	0.00277	0.00315	CcSEcCtD
Vardenafil—Vomiting—Hydroxyurea—head and neck cancer	0.00277	0.00315	CcSEcCtD
Vardenafil—Dyspepsia—Fluorouracil—head and neck cancer	0.00276	0.00314	CcSEcCtD
Vardenafil—Rash—Hydroxyurea—head and neck cancer	0.00274	0.00312	CcSEcCtD
Vardenafil—Dermatitis—Hydroxyurea—head and neck cancer	0.00274	0.00312	CcSEcCtD
Vardenafil—Headache—Hydroxyurea—head and neck cancer	0.00273	0.0031	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.0027	0.00308	CcSEcCtD
Vardenafil—Back pain—Docetaxel—head and neck cancer	0.00268	0.00305	CcSEcCtD
Vardenafil—Pain—Fluorouracil—head and neck cancer	0.00268	0.00305	CcSEcCtD
Vardenafil—PDE10A—thyroid gland—head and neck cancer	0.00267	0.0645	CbGeAlD
Vardenafil—Muscle spasms—Docetaxel—head and neck cancer	0.00266	0.00303	CcSEcCtD
Vardenafil—PDE1B—thyroid gland—head and neck cancer	0.00264	0.0639	CbGeAlD
Vardenafil—Nausea—Hydroxyurea—head and neck cancer	0.00258	0.00294	CcSEcCtD
Vardenafil—Feeling abnormal—Fluorouracil—head and neck cancer	0.00258	0.00294	CcSEcCtD
Vardenafil—Syncope—Docetaxel—head and neck cancer	0.00248	0.00283	CcSEcCtD
Vardenafil—PDE6G—lymph node—head and neck cancer	0.00245	0.0593	CbGeAlD
Vardenafil—Palpitations—Docetaxel—head and neck cancer	0.00245	0.00279	CcSEcCtD
Vardenafil—Loss of consciousness—Docetaxel—head and neck cancer	0.00243	0.00277	CcSEcCtD
Vardenafil—Convulsion—Docetaxel—head and neck cancer	0.0024	0.00273	CcSEcCtD
Vardenafil—PDE10A—head—head and neck cancer	0.00237	0.0572	CbGeAlD
Vardenafil—Arthralgia—Docetaxel—head and neck cancer	0.00236	0.00268	CcSEcCtD
Vardenafil—Chest pain—Docetaxel—head and neck cancer	0.00236	0.00268	CcSEcCtD
Vardenafil—Myalgia—Docetaxel—head and neck cancer	0.00236	0.00268	CcSEcCtD
Vardenafil—PDE5A—connective tissue—head and neck cancer	0.00235	0.0568	CbGeAlD
Vardenafil—PDE1B—head—head and neck cancer	0.00234	0.0567	CbGeAlD
Vardenafil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00234	0.00267	CcSEcCtD
Vardenafil—Hypersensitivity—Fluorouracil—head and neck cancer	0.00231	0.00263	CcSEcCtD
Vardenafil—Dry mouth—Docetaxel—head and neck cancer	0.00231	0.00262	CcSEcCtD
Vardenafil—Anaphylactic shock—Docetaxel—head and neck cancer	0.00226	0.00257	CcSEcCtD
Vardenafil—Infection—Docetaxel—head and neck cancer	0.00225	0.00256	CcSEcCtD
Vardenafil—PDE5A—epithelium—head and neck cancer	0.00223	0.0539	CbGeAlD
Vardenafil—Shock—Docetaxel—head and neck cancer	0.00222	0.00253	CcSEcCtD
Vardenafil—Nervous system disorder—Docetaxel—head and neck cancer	0.00222	0.00252	CcSEcCtD
Vardenafil—Pruritus—Fluorouracil—head and neck cancer	0.00222	0.00252	CcSEcCtD
Vardenafil—Tachycardia—Docetaxel—head and neck cancer	0.00221	0.00251	CcSEcCtD
Vardenafil—Skin disorder—Docetaxel—head and neck cancer	0.0022	0.0025	CcSEcCtD
Vardenafil—Diarrhoea—Fluorouracil—head and neck cancer	0.00214	0.00244	CcSEcCtD
Vardenafil—Hypotension—Docetaxel—head and neck cancer	0.00211	0.0024	CcSEcCtD
Vardenafil—Dizziness—Fluorouracil—head and neck cancer	0.00207	0.00236	CcSEcCtD
Vardenafil—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00206	0.00234	CcSEcCtD
Vardenafil—Insomnia—Docetaxel—head and neck cancer	0.00204	0.00233	CcSEcCtD
Vardenafil—Paraesthesia—Docetaxel—head and neck cancer	0.00203	0.00231	CcSEcCtD
Vardenafil—Dyspnoea—Docetaxel—head and neck cancer	0.00202	0.00229	CcSEcCtD
Vardenafil—Somnolence—Docetaxel—head and neck cancer	0.00201	0.00229	CcSEcCtD
Vardenafil—Vomiting—Fluorouracil—head and neck cancer	0.00199	0.00227	CcSEcCtD
Vardenafil—Dyspepsia—Docetaxel—head and neck cancer	0.00199	0.00226	CcSEcCtD
Vardenafil—Rash—Fluorouracil—head and neck cancer	0.00197	0.00225	CcSEcCtD
Vardenafil—Dermatitis—Fluorouracil—head and neck cancer	0.00197	0.00225	CcSEcCtD
Vardenafil—Headache—Fluorouracil—head and neck cancer	0.00196	0.00223	CcSEcCtD
Vardenafil—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00195	0.00222	CcSEcCtD
Vardenafil—Pain—Docetaxel—head and neck cancer	0.00193	0.0022	CcSEcCtD
Vardenafil—Feeling abnormal—Docetaxel—head and neck cancer	0.00186	0.00212	CcSEcCtD
Vardenafil—Nausea—Fluorouracil—head and neck cancer	0.00186	0.00212	CcSEcCtD
Vardenafil—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00185	0.0021	CcSEcCtD
Vardenafil—Abdominal pain—Docetaxel—head and neck cancer	0.00179	0.00203	CcSEcCtD
Vardenafil—Hypersensitivity—Docetaxel—head and neck cancer	0.00167	0.0019	CcSEcCtD
Vardenafil—PDE10A—lymph node—head and neck cancer	0.00166	0.0401	CbGeAlD
Vardenafil—PDE1B—lymph node—head and neck cancer	0.00164	0.0397	CbGeAlD
Vardenafil—Asthenia—Docetaxel—head and neck cancer	0.00162	0.00185	CcSEcCtD
Vardenafil—Pruritus—Docetaxel—head and neck cancer	0.0016	0.00182	CcSEcCtD
Vardenafil—PDE5A—thyroid gland—head and neck cancer	0.00156	0.0377	CbGeAlD
Vardenafil—Diarrhoea—Docetaxel—head and neck cancer	0.00155	0.00176	CcSEcCtD
Vardenafil—Dizziness—Docetaxel—head and neck cancer	0.00149	0.0017	CcSEcCtD
Vardenafil—Vomiting—Docetaxel—head and neck cancer	0.00144	0.00164	CcSEcCtD
Vardenafil—Rash—Docetaxel—head and neck cancer	0.00143	0.00162	CcSEcCtD
Vardenafil—Dermatitis—Docetaxel—head and neck cancer	0.00142	0.00162	CcSEcCtD
Vardenafil—Headache—Docetaxel—head and neck cancer	0.00142	0.00161	CcSEcCtD
Vardenafil—PDE5A—head—head and neck cancer	0.00138	0.0335	CbGeAlD
Vardenafil—Nausea—Docetaxel—head and neck cancer	0.00134	0.00153	CcSEcCtD
Vardenafil—PDE5A—lymph node—head and neck cancer	0.000969	0.0234	CbGeAlD
Vardenafil—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000185	0.00343	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—MAPK3—head and neck cancer	0.000185	0.00342	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	0.000183	0.00339	CbGpPWpGaD
Vardenafil—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	0.000181	0.00335	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—MAPK3—head and neck cancer	0.00018	0.00334	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—MAPK1—head and neck cancer	0.00018	0.00333	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—MAPK1—head and neck cancer	0.00018	0.00333	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—EGFR—head and neck cancer	0.00018	0.00333	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—EGFR—head and neck cancer	0.00018	0.00333	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—PIK3CA—head and neck cancer	0.000179	0.00331	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—MAPK1—head and neck cancer	0.000178	0.0033	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—EGFR—head and neck cancer	0.000178	0.0033	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—MAPK1—head and neck cancer	0.000176	0.00327	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—EGFR—head and neck cancer	0.000176	0.00327	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—MAPK1—head and neck cancer	0.000176	0.00325	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—EGFR—head and neck cancer	0.000176	0.00325	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—STAT3—head and neck cancer	0.000175	0.00324	CbGpPWpGaD
Vardenafil—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	0.000174	0.00322	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000172	0.00319	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—MAPK1—head and neck cancer	0.000172	0.00318	CbGpPWpGaD
Vardenafil—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000171	0.00317	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.00017	0.00315	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—VEGFA—head and neck cancer	0.00017	0.00315	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—VEGFA—head and neck cancer	0.00017	0.00315	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—PIK3CA—head and neck cancer	0.000168	0.00311	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—PIK3CA—head and neck cancer	0.000167	0.0031	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—MAPK3—head and neck cancer	0.000167	0.0031	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—PIK3CA—head and neck cancer	0.000167	0.00308	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—PIK3CA—head and neck cancer	0.000166	0.00307	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—HRAS—head and neck cancer	0.000166	0.00307	CbGpPWpGaD
Vardenafil—PDE6G—Signaling by Wnt—AKT1—head and neck cancer	0.000162	0.003	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—MAPK3—head and neck cancer	0.000161	0.00298	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—MAPK3—head and neck cancer	0.000161	0.00298	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—MAPK1—head and neck cancer	0.000159	0.00295	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—EGFR—head and neck cancer	0.000159	0.00295	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—KISS1—head and neck cancer	0.000157	0.0029	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—PIK3CA—head and neck cancer	0.000156	0.00289	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—PIK3CA—head and neck cancer	0.000156	0.00289	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—HRAS—head and neck cancer	0.000156	0.00288	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—HRAS—head and neck cancer	0.000155	0.00287	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—PIK3CA—head and neck cancer	0.000155	0.00286	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—HRAS—head and neck cancer	0.000154	0.00285	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—HRAS—head and neck cancer	0.000153	0.00284	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—PIK3CA—head and neck cancer	0.000153	0.00284	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—MAPK1—head and neck cancer	0.000153	0.00283	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—MAPK1—head and neck cancer	0.000153	0.00283	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—UROD—head and neck cancer	0.000153	0.00283	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—PIK3CA—head and neck cancer	0.000152	0.00282	CbGpPWpGaD
Vardenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000152	0.00281	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—PTEN—head and neck cancer	0.000151	0.00279	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—PIK3CA—head and neck cancer	0.000149	0.00276	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—BCL2L1—head and neck cancer	0.000148	0.00274	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signaling of activated FGFR—AKT1—head and neck cancer	0.000146	0.00271	CbGpPWpGaD
Vardenafil—PDE6G—Disease—NOTCH1—head and neck cancer	0.000144	0.00267	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—HRAS—head and neck cancer	0.000144	0.00267	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—HRAS—head and neck cancer	0.000144	0.00267	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—TP53—head and neck cancer	0.000144	0.00267	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—HRAS—head and neck cancer	0.000143	0.00265	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—IL2—head and neck cancer	0.000142	0.00263	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—HRAS—head and neck cancer	0.000142	0.00262	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—HRAS—head and neck cancer	0.000141	0.00261	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—PIK3CA—head and neck cancer	0.000138	0.00256	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—HRAS—head and neck cancer	0.000138	0.00255	CbGpPWpGaD
Vardenafil—PDE1B—Downstream signal transduction—AKT1—head and neck cancer	0.000137	0.00254	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR—AKT1—head and neck cancer	0.000137	0.00253	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by ERBB2—AKT1—head and neck cancer	0.000136	0.00252	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 signaling—AKT1—head and neck cancer	0.000135	0.00251	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—STAT3—head and neck cancer	0.000135	0.00249	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—PIK3CA—head and neck cancer	0.000133	0.00246	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—PIK3CA—head and neck cancer	0.000133	0.00246	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—GRP—head and neck cancer	0.000129	0.00239	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—IL2—head and neck cancer	0.000129	0.00239	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—MAPK3—head and neck cancer	0.000129	0.00238	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—TP53—head and neck cancer	0.000128	0.00238	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—TP53—head and neck cancer	0.000128	0.00238	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—HRAS—head and neck cancer	0.000128	0.00237	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by FGFR in disease—AKT1—head and neck cancer	0.000127	0.00236	CbGpPWpGaD
Vardenafil—PDE1B—DAP12 interactions—AKT1—head and neck cancer	0.000127	0.00236	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—IL2—head and neck cancer	0.000126	0.00234	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR—AKT1—head and neck cancer	0.000126	0.00234	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—STAT6—head and neck cancer	0.000125	0.00232	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by EGFR in Cancer—AKT1—head and neck cancer	0.000125	0.00232	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by PDGF—AKT1—head and neck cancer	0.000125	0.00231	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—HRAS—head and neck cancer	0.000123	0.00227	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—HRAS—head and neck cancer	0.000123	0.00227	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—MAPK1—head and neck cancer	0.000122	0.00227	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—EGFR—head and neck cancer	0.000122	0.00227	CbGpPWpGaD
Vardenafil—PDE11A—Hemostasis—AKT1—head and neck cancer	0.000122	0.00225	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—CASP8—head and neck cancer	0.000121	0.00224	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—IL2—head and neck cancer	0.000115	0.00213	CbGpPWpGaD
Vardenafil—PDE1B—NGF signalling via TRKA from the plasma membrane—AKT1—head and neck cancer	0.000113	0.00209	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—YAP1—head and neck cancer	0.000111	0.00205	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—NOTCH1—head and neck cancer	0.000111	0.00205	CbGpPWpGaD
Vardenafil—PDE10A—Hemostasis—AKT1—head and neck cancer	0.000108	0.00201	CbGpPWpGaD
Vardenafil—PDE5A—Hemostasis—AKT1—head and neck cancer	0.000108	0.00201	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PTGS2—head and neck cancer	0.000107	0.00199	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—PIK3CA—head and neck cancer	0.000106	0.00197	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—BCL2—head and neck cancer	0.000104	0.00192	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—MAPK3—head and neck cancer	0.000104	0.00192	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—IL2—head and neck cancer	0.000101	0.00188	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—NOTCH1—head and neck cancer	0.000101	0.00187	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—NOTCH1—head and neck cancer	9.85e-05	0.00182	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—MAPK1—head and neck cancer	9.85e-05	0.00182	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—EGFR—head and neck cancer	9.85e-05	0.00182	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—HRAS—head and neck cancer	9.83e-05	0.00182	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—PIK3CA—head and neck cancer	9.41e-05	0.00174	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PTEN—head and neck cancer	9.35e-05	0.00173	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—MAPK3—head and neck cancer	9.23e-05	0.00171	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—MAPK1—head and neck cancer	8.78e-05	0.00163	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—EGFR—head and neck cancer	8.78e-05	0.00163	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by NGF—AKT1—head and neck cancer	8.68e-05	0.00161	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—VEGFA—head and neck cancer	8.62e-05	0.0016	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BCL2L1—head and neck cancer	8.61e-05	0.00159	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—PTEN—head and neck cancer	8.59e-05	0.00159	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—PIK3CA—head and neck cancer	8.55e-05	0.00158	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	8.51e-05	0.00158	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	8.4e-05	0.00156	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—PIK3CA—head and neck cancer	8.39e-05	0.00155	CbGpPWpGaD
Vardenafil—PDE6G—Disease—STAT3—head and neck cancer	8.36e-05	0.00155	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—MAPK3—head and neck cancer	8.15e-05	0.00151	CbGpPWpGaD
Vardenafil—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	8.07e-05	0.00149	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MAPK3—head and neck cancer	7.99e-05	0.00148	CbGpPWpGaD
Vardenafil—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	7.96e-05	0.00147	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—HRAS—head and neck cancer	7.91e-05	0.00146	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—MAPK1—head and neck cancer	7.75e-05	0.00144	CbGpPWpGaD
Vardenafil—PDE11A—GPCR downstream signaling—AKT1—head and neck cancer	7.69e-05	0.00142	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—PIK3CA—head and neck cancer	7.62e-05	0.00141	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—IL2—head and neck cancer	7.61e-05	0.00141	CbGpPWpGaD
Vardenafil—PDE6G—Disease—MAPK1—head and neck cancer	7.6e-05	0.00141	CbGpPWpGaD
Vardenafil—PDE6G—Disease—EGFR—head and neck cancer	7.6e-05	0.00141	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—CCND1—head and neck cancer	7.42e-05	0.00137	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MAPK3—head and neck cancer	7.34e-05	0.00136	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PTEN—head and neck cancer	7.16e-05	0.00133	CbGpPWpGaD
Vardenafil—PDE1B—Disease—NOTCH1—head and neck cancer	7.13e-05	0.00132	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—UROD—head and neck cancer	7.1e-05	0.00131	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—HRAS—head and neck cancer	7.05e-05	0.00131	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CASP8—head and neck cancer	7.04e-05	0.0013	CbGpPWpGaD
Vardenafil—PDE11A—Signaling by GPCR—AKT1—head and neck cancer	6.98e-05	0.00129	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—MAPK1—head and neck cancer	6.98e-05	0.00129	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—EGFR—head and neck cancer	6.98e-05	0.00129	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—IL2—head and neck cancer	6.96e-05	0.00129	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—CDH1—head and neck cancer	6.95e-05	0.00129	CbGpPWpGaD
Vardenafil—PDE10A—GPCR downstream signaling—AKT1—head and neck cancer	6.85e-05	0.00127	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—CCND1—head and neck cancer	6.78e-05	0.00126	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—IL2—head and neck cancer	6.78e-05	0.00126	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—PIK3CA—head and neck cancer	6.73e-05	0.00125	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—CCND1—head and neck cancer	6.61e-05	0.00122	CbGpPWpGaD
Vardenafil—PDE6G—Disease—PIK3CA—head and neck cancer	6.6e-05	0.00122	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PTEN—head and neck cancer	6.55e-05	0.00121	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—TP53—head and neck cancer	6.51e-05	0.00121	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—VEGFA—head and neck cancer	6.47e-05	0.0012	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—IL2—head and neck cancer	6.41e-05	0.00119	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—STAT3—head and neck cancer	6.4e-05	0.00119	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PTEN—head and neck cancer	6.38e-05	0.00118	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—NAT2—head and neck cancer	6.34e-05	0.00117	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—HRAS—head and neck cancer	6.23e-05	0.00115	CbGpPWpGaD
Vardenafil—PDE10A—Signaling by GPCR—AKT1—head and neck cancer	6.22e-05	0.00115	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MAPK3—head and neck cancer	6.12e-05	0.00113	CbGpPWpGaD
Vardenafil—PDE6G—Disease—HRAS—head and neck cancer	6.1e-05	0.00113	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—PIK3CA—head and neck cancer	6.06e-05	0.00112	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—BCL2—head and neck cancer	6.04e-05	0.00112	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—VEGFA—head and neck cancer	5.91e-05	0.0011	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—STAT3—head and neck cancer	5.86e-05	0.00108	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—MAPK1—head and neck cancer	5.82e-05	0.00108	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—EGFR—head and neck cancer	5.82e-05	0.00108	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—IL2—head and neck cancer	5.82e-05	0.00108	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—VEGFA—head and neck cancer	5.76e-05	0.00107	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—STAT3—head and neck cancer	5.71e-05	0.00106	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—HRAS—head and neck cancer	5.6e-05	0.00104	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MAPK3—head and neck cancer	5.59e-05	0.00104	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—DPYD—head and neck cancer	5.56e-05	0.00103	CbGpPWpGaD
Vardenafil—PDE1B—Hemostasis—AKT1—head and neck cancer	5.5e-05	0.00102	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAPK3—head and neck cancer	5.45e-05	0.00101	CbGpPWpGaD
Vardenafil—PDE6G—Disease—AKT1—head and neck cancer	5.39e-05	0.000998	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—MAPK1—head and neck cancer	5.32e-05	0.000986	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—EGFR—head and neck cancer	5.32e-05	0.000986	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—IL2—head and neck cancer	5.32e-05	0.000984	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTGS2—head and neck cancer	5.3e-05	0.000981	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—YAP1—head and neck cancer	5.28e-05	0.000977	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—MAPK1—head and neck cancer	5.19e-05	0.000961	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—EGFR—head and neck cancer	5.19e-05	0.00096	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—PIK3CA—head and neck cancer	5.05e-05	0.000935	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PTEN—head and neck cancer	5e-05	0.000926	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—NOTCH1—head and neck cancer	4.99e-05	0.000925	CbGpPWpGaD
Vardenafil—PDE1B—Innate Immune System—AKT1—head and neck cancer	4.95e-05	0.000916	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—TP53—head and neck cancer	4.89e-05	0.000905	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—MAPK3—head and neck cancer	4.68e-05	0.000866	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—HRAS—head and neck cancer	4.67e-05	0.000865	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—PIK3CA—head and neck cancer	4.62e-05	0.000855	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PTEN—head and neck cancer	4.62e-05	0.000855	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—PIK3CA—head and neck cancer	4.5e-05	0.000834	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—STAT3—head and neck cancer	4.47e-05	0.000828	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—TP53—head and neck cancer	4.47e-05	0.000827	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—MAPK1—head and neck cancer	4.45e-05	0.000824	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—EGFR—head and neck cancer	4.45e-05	0.000824	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—TP53—head and neck cancer	4.35e-05	0.000806	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK3—head and neck cancer	4.27e-05	0.000791	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—HRAS—head and neck cancer	4.27e-05	0.000791	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—PIK3CA—head and neck cancer	4.25e-05	0.000788	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—HRAS—head and neck cancer	4.16e-05	0.000771	CbGpPWpGaD
Vardenafil—PDE1B—Disease—STAT3—head and neck cancer	4.13e-05	0.000765	CbGpPWpGaD
Vardenafil—PDE11A—Signaling Pathways—AKT1—head and neck cancer	4.13e-05	0.000764	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—MAPK1—head and neck cancer	4.07e-05	0.000753	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—EGFR—head and neck cancer	4.07e-05	0.000753	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MAPK3—head and neck cancer	3.95e-05	0.000731	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—PIK3CA—head and neck cancer	3.86e-05	0.000715	CbGpPWpGaD
Vardenafil—PDE6G—Signaling Pathways—AKT1—head and neck cancer	3.77e-05	0.000699	CbGpPWpGaD
Vardenafil—PDE1B—Disease—MAPK1—head and neck cancer	3.75e-05	0.000695	CbGpPWpGaD
Vardenafil—PDE1B—Disease—EGFR—head and neck cancer	3.75e-05	0.000695	CbGpPWpGaD
Vardenafil—PDE10A—Signaling Pathways—AKT1—head and neck cancer	3.68e-05	0.000681	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—HRAS—head and neck cancer	3.57e-05	0.000662	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—PIK3CA—head and neck cancer	3.53e-05	0.000653	CbGpPWpGaD
Vardenafil—PDE1B—GPCR downstream signaling—AKT1—head and neck cancer	3.47e-05	0.000643	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—IL2—head and neck cancer	3.44e-05	0.000636	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—CCND1—head and neck cancer	3.35e-05	0.00062	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—HRAS—head and neck cancer	3.26e-05	0.000605	CbGpPWpGaD
Vardenafil—PDE1B—Disease—PIK3CA—head and neck cancer	3.26e-05	0.000603	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PTEN—head and neck cancer	3.23e-05	0.000599	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—TYMS—head and neck cancer	3.17e-05	0.000587	CbGpPWpGaD
Vardenafil—PDE1B—Signaling by GPCR—AKT1—head and neck cancer	3.15e-05	0.000584	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GSTM1—head and neck cancer	3.13e-05	0.00058	CbGpPWpGaD
Vardenafil—PDE1B—Disease—HRAS—head and neck cancer	3.01e-05	0.000558	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—GPX1—head and neck cancer	3e-05	0.000555	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—CYP1A1—head and neck cancer	2.97e-05	0.00055	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—NAT2—head and neck cancer	2.95e-05	0.000546	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—VEGFA—head and neck cancer	2.92e-05	0.000541	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—STAT3—head and neck cancer	2.89e-05	0.000536	CbGpPWpGaD
Vardenafil—PDE1B—Immune System—AKT1—head and neck cancer	2.88e-05	0.000534	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK3—head and neck cancer	2.76e-05	0.000512	CbGpPWpGaD
Vardenafil—PDE1B—Disease—AKT1—head and neck cancer	2.66e-05	0.000493	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—MAPK1—head and neck cancer	2.63e-05	0.000487	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—EGFR—head and neck cancer	2.63e-05	0.000487	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—DPYD—head and neck cancer	2.59e-05	0.000479	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—YAP1—head and neck cancer	2.45e-05	0.000454	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—PIK3CA—head and neck cancer	2.28e-05	0.000422	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—TP53—head and neck cancer	2.21e-05	0.000409	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—HRAS—head and neck cancer	2.11e-05	0.000391	CbGpPWpGaD
Vardenafil—PDE1B—Signaling Pathways—AKT1—head and neck cancer	1.86e-05	0.000345	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.77e-05	0.000327	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PTEN—head and neck cancer	1.54e-05	0.000285	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—TYMS—head and neck cancer	1.47e-05	0.000273	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.46e-05	0.00027	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—GPX1—head and neck cancer	1.39e-05	0.000258	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.38e-05	0.000256	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.09e-05	0.000201	CbGpPWpGaD
Vardenafil—CYP3A5—Metabolism—AKT1—head and neck cancer	8.87e-06	0.000164	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTGS2—head and neck cancer	8.21e-06	0.000152	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PTEN—head and neck cancer	7.16e-06	0.000133	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—PIK3CA—head and neck cancer	5.05e-06	9.35e-05	CbGpPWpGaD
Vardenafil—CYP3A4—Metabolism—AKT1—head and neck cancer	4.13e-06	7.64e-05	CbGpPWpGaD
